Prevention of in vivo excitotoxicity by a family of trialkylglycines, a novel class of neuroprotectants

Journal of Pharmacology and Experimental Therapeutics

Volumn 301, Issue 1, 2002, Pages 29-36

  Montoliu, Carmina ^a   Humet, Marc ^b   Canales, Juan José ^a   Burda, Jozef ^a   Planells Cases, Rosa ^c   Sánchez Baeza, Francisco ^b   Carbonell, Teresa ^d   Pérez Payá, Enrique ^d   Messeguer, Angel ^b   Ferrer Montiel, Antonio ^c   Felipo, Vicente ^a  

^a Laboratorio de Neurobiologia de Prince Felipe Research Centre   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLYCINE DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PEPTOID 6 1 10; PEPTOID 6 1 2; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DRUG TOLERABILITY; ENZYME ACTIVATION; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

AMMONIA; ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CALCIUM; CASPASE 3; CASPASES; CELL DEATH; CELLS, CULTURED; COMBINATORIAL CHEMISTRY TECHNIQUES; CYCLIC GMP; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACIDS; GLUTAMIC ACID; INJECTIONS, INTRAPERITONEAL; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; PEPTOIDS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SILVER STAINING;

EID: 18344367059     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.301.1.29     Document Type: Article

References (37)

1. Silver staining as a tool for neurotoxic assessment
2. Ligands for glutamate receptors: Design and therapeutic prospects
3. Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications
4. Antagonists selective for NMDA receptors containing the NR2B subunit
5. Ionic dependence of glutamate neurotoxicity
6. The role of glutamate neurotoxicity in hypoxicischemic neuronal death
7. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures
8. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
9. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
10. Inhibitors of protein kinase C prevent the toxicity of glutamate in primary neuronal cultures
11. Selected peptides targeted to the NMDA receptor channel protect neurons from excitotoxic death
12. Synthesis of N-substituted glycine peptoid libraries
13. Formation of"dark" (argyrophilic) neurons of various origin proceeds with a common mechanism of biophysical nature (a novel hypothesis)
14. NMDA receptors, neuronal development, and neurodegeneration
15. NMDA receptor antagonists prevent acute ammonia toxicity in mice
16. Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: Characterization by in vivo brain microdialysis
17. Chronic hyperammonemia impairs glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo
18. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain
19. Neuronal death enhanced by N-methyl-D-aspartate antagonists
20. The mitochondrial death/life regulator in apoptosis and necrosis
21. Nitric oxide, superoxide and peroxynitrite: Putative mediators of NMDA-induced cell death in cerebellar granule cells
22. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
23. Excitatory amino acids as a final common pathway for neurologic disorders
24. Acute ammonia toxicity is mediated by NMDA type of glutamate receptors
25. Ammonia prevents activation of NMDA receptors by glutamate in rat cerebellar neuronal cultures
26. Lack of correlation between glutamate-induced depletion of ATP and neuronal death in primary cultures of cerebellum
27. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose
28. Carnitina and choline derivates containing a trimethylamine group prevent ammonia toxicity in mice and glutamate toxicity in primary cultures of neurons
29. Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons
30. Role of cyclic GMP in glutamate neurotoxicity in primary cultures of cerebellar neurons
31. The role of NMDA receptors in learning and memory
32. Molecular diversity in drug design. Application to high-speed synthesis and high-throughput screening
33. Ethanol-induced apoptotic neurodegeneration in the developing brain
34. Peptomers: A versatile approach for the preparation of diverse combinatorial peptidomimetic bead libraries
35. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries
36. A new model of bilateral hemispheric ischemia in the unanesthetized rat
37. A modified four-vessel occlusion model for inducing incomplete forebrain ischemia in rats